Table 1. Baseline characteristics of all enrolled patients (N = 44).
| Demographic criteria | Number of patients in each group | Percentage (%) |
|---|---|---|
| Age at diagnosis (N = 44) | ||
| 40–49 years | 4 | 9.1 |
| 50–59 years | 14 | 32.8 |
| 60–69 years | 19 | 43.2 |
| >70 years | 7 | 15.9 |
| Race/Ethnicity (N = 44) | ||
| White, non-Jewish | 22 | 50 |
| Jewish | 11 | 25 |
| Black | 5 | 11.4 |
| Asian | 2 | 4.5 |
| Hispanic | 1 | 2.3 |
| Unknown/Other | 3 | 6.8 |
| BRCA Status (N = 44) | ||
| Positive | 11 | 25 |
| Negative | 8 | 18.2 |
| Unknown | 25 | 56.8 |
| Histology classification by primary site | ||
| Ovary (N = 22) | ||
| Serous | 21 | 95.5 |
| Malignant Mixed Mesodermal Tumor | 1 | 4.5 |
| Uterus (N = 17) | ||
| Papillary Serous | 8 | 47.1 |
| Malignant Mixed Mesodermal Tumor | 3 | 17.6 |
| Mixed | 3 | 17.6 |
| Clear Cell | 2 | 11.8 |
| Endometrioid | 1 | 5.9 |
| Peritoneal (N = 1) | ||
| Serous | 1 | 100 |
| Fallopian Tube (N = 3) | ||
| Serous | 3 | 100 |
| Synchronous fallopian tube & uterine (N = 1) | ||
| 1 | 100 | |
| Stage at diagnosis (N = 44) | ||
| 1 | 5 | 11.4 |
| 2 | 2 | 4.5 |
| 3 | 23 | 52.3 |
| 4 | 13 | 29.5 |
| Unstaged | 1 | 2.3 |